Article
HLA-DQ barrier: effects on cPRA calculations.
Transplantation - 27 Dec 2013
Tambur Anat R, Leventhal Joseph R, Walsh R Carlin, Zitzner Jennifer R, Friedewald John J
Abstract excerpt
BACKGROUND: Panel-reactive antibody (PRA) testing provides assessment of the breadth of sensitization a patient might have against human leukocyte antigen (HLA) antigens. The evolution of calculated PRA (cPRA) reflects the commitment of the transplant community to increase accessibility and promote equity to all patients awaiting kidney transplantation. Recent data from our center and others, however, suggested...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
